Add like
Add dislike
Add to saved papers

Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: a nationwide cohort study.

IMPORTANCE: The association between visual deficits and attention disorders has been reported but remains unproven.

BACKGROUND: The objective of this study was to evaluate the risk of attention-deficit hyperactivity disorder (ADHD) in children with amblyopia.

DESIGN: Population-based, cohort study.

PARTICIPANTS: The dataset from the Taiwan National Health Insurance Research Database in 2000-2010.

METHODS: A total of 6817 patients aged <18 years with newly diagnosed amblyopia were identified. Four age-matched and sex-matched controls without amblyopia were included for each patient, i.e., 27,268 controls.

MAIN OUTCOME MEASURES: The primary outcome was the risk of ADHD. The secondary outcomes were age at ADHD onset and use of ADHD medication.

RESULTS: During a mean observation period of 7.18 years, the incidence of ADHD per 1000 person-years was 7.02 in the amblyopia group and 4.61 in the control group (P<0.0001). The ADHD risk in the amblyopia group was 1.81 times that in the control group (hazard ratio 1.81; 95% confidence interval 1.59-2.06). After stratification by amblyopia subtype, the greatest risk was in the deprivation type (hazard ratio 2.14; 95% confidence interval 1.56-2.92) followed by the strabismic (hazard ratio 2.09; 95% confidence interval 1.15-3.79) and refractive (hazard ratio 1.76; 95% confidence interval 1.54-2.02) types. Age at ADHD onset was younger in the amblyopia group (median 8.14 versus 8.45 years; P=0.0096). The average duration of neuropsychiatric medication was comparable between groups (P=0.98).

CONCLUSIONS AND RELEVANCE: The ADHD risk is higher in children with amblyopia.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app